全文获取类型
收费全文 | 131097篇 |
免费 | 9159篇 |
国内免费 | 3461篇 |
专业分类
耳鼻咽喉 | 943篇 |
儿科学 | 3864篇 |
妇产科学 | 1448篇 |
基础医学 | 8493篇 |
口腔科学 | 1078篇 |
临床医学 | 17368篇 |
内科学 | 36814篇 |
皮肤病学 | 657篇 |
神经病学 | 3230篇 |
特种医学 | 3029篇 |
外国民族医学 | 1篇 |
外科学 | 13551篇 |
综合类 | 23516篇 |
现状与发展 | 6篇 |
一般理论 | 5篇 |
预防医学 | 7067篇 |
眼科学 | 269篇 |
药学 | 12401篇 |
131篇 | |
中国医学 | 8345篇 |
肿瘤学 | 1501篇 |
出版年
2024年 | 99篇 |
2023年 | 1973篇 |
2022年 | 3124篇 |
2021年 | 5119篇 |
2020年 | 5202篇 |
2019年 | 4545篇 |
2018年 | 4412篇 |
2017年 | 4322篇 |
2016年 | 4486篇 |
2015年 | 4553篇 |
2014年 | 9829篇 |
2013年 | 9812篇 |
2012年 | 7997篇 |
2011年 | 8826篇 |
2010年 | 7011篇 |
2009年 | 6500篇 |
2008年 | 6307篇 |
2007年 | 6370篇 |
2006年 | 5662篇 |
2005年 | 5033篇 |
2004年 | 3994篇 |
2003年 | 3453篇 |
2002年 | 2875篇 |
2001年 | 2633篇 |
2000年 | 2152篇 |
1999年 | 2042篇 |
1998年 | 1624篇 |
1997年 | 1516篇 |
1996年 | 1293篇 |
1995年 | 1258篇 |
1994年 | 1253篇 |
1993年 | 925篇 |
1992年 | 876篇 |
1991年 | 801篇 |
1990年 | 688篇 |
1989年 | 649篇 |
1988年 | 577篇 |
1987年 | 493篇 |
1986年 | 433篇 |
1985年 | 491篇 |
1984年 | 440篇 |
1983年 | 265篇 |
1982年 | 308篇 |
1981年 | 268篇 |
1980年 | 253篇 |
1979年 | 212篇 |
1978年 | 176篇 |
1977年 | 152篇 |
1976年 | 137篇 |
1975年 | 81篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
61.
目的探析西地兰联合胺碘酮治疗急诊重症心衰合并快速性心律失常患者的临床效果。方法60例急诊重症心衰合并快速性心律失常患者,以电脑Excel表格按照1∶1比例分为对比组和研究组,每组30例,对比组患者采用西地兰治疗,研究组患者采用西地兰联合胺碘酮治疗。比较两组患者治疗前后QT离散度、心功能指标及治疗后临床指标。结果治疗后,两组患者QT离散度均较本组治疗前降低,且研究组患者QT离散度(32.69±2.69)ms低于对比组的(41.32±3.11)ms,差异具有统计学意义(P<0.05)。治疗后,研究组患者心室率(78.51±5.17)次/min低于对比组的(94.23±6.67)次/min,起效时间(18.23±2.11)min短于对比组的(32.11±3.51)min,窦性心律转复率93.33%(28/30)高于对比组的70.00%(21/30),差异具有统计学意义(P<0.05)。治疗后,两组患者左室舒张末期内径、室间隔厚度、左室后壁厚度、左室重量指数、左室射血分数、舒张早期最大流速/舒张晚期最大流速(E/A)、N末端B型脑钠肽前体(NT-proBNP)水平均较本组治疗前改善,且研究组优于对比组,差异具有统计学意义(P<0.05)。结论在急诊重症心衰合并快速性心律失常患者治疗中选择西地兰联合胺碘酮用药方案,能够更好降低QT离散度,提高窦性心律转复率,且心室率更低、起效时间更短,同时,在改善心功能方面效果较显著。 相似文献
62.
《Journal of Radiology Nursing》2022,41(1):33-37
ObjectiveThis study sought to evaluate the effectiveness of diltiazem at achieving a targeted heart rate (HR) of ≤75 bpm in orthotopic heart transplant patients during coronary computed tomography (CT) angiography.MethodsBaseline heart rates were compared to heart rates after diltiazem administration in 25 adult orthotopic heart transplant subjects being monitored by electrocardiogram (ECG) gaiting on a multidetector CT scanner.ResultsThe mean baseline HR of the group was 84.28 ± 11.305 bpm. After diltiazem administration, the mean heart rate of the group at the time of the coronary CT angiography study was 75.32 ± 9.49 bpm. Heart rates decreased in 23 subjects (92%) and the targeted heart rate of ≤75 bpm was observed in 13 subjects (52%).ConclusionDiltiazem administration was associated with a decrease in heart rate, yet reaching the targeted heart rate was limited. Further study regarding diltiazem dosing and its impact is warranted. 相似文献
63.
采用Mimics对心脏进行三维重构,用3-matic进行模型优化以及模型误差分析,对左心室室壁运动做速度分布假设,基于UDF宏文件对左心室室壁运动编写程序,将血液视为非牛顿流体,采用动网格技术研究不同血压对左心室血液流动的影响。模拟发现当左心室收缩时,压力梯度明显,内部压力减小。当左心室舒张时,内部压力逐渐增高。二尖瓣口处的速率先增大后减小。血压升高,左心室内剪切应力持续增大,极易破坏红细胞结构,产生溶血现象,导致心脏功能紊乱。 相似文献
64.
含SAM尖端结构域的E26转化特异性因子(SPDEF)是ETS转录因子家族的最新成员之一, SPDEF又称为前列腺源性ETS因子(PDEF),首次发现其在前列腺癌中高度表达,参与肿瘤细胞的增殖分化、迁移凋亡和血管形成。近年来研究发现SPDEF与杯状细胞增生和分化密切相关,是调控呼吸道黏液高分泌的核心因子。对SPDEF调控黏液高分泌的机制及其在呼吸道慢性炎性疾病中的研究进展做一综述,以期为呼吸道黏液高分泌疾病的发病机制和诊治提供新思路。 相似文献
65.
66.
《Enfermería clínica》2022,32(3):171-183
IntroductionAgeing is a period of physical and psychological changes. Inactivity is one of the biggest problems among the older adult population increasing the risk of sarcopenia and chronic diseases. Physical activity is an effective intervention to improve health outcomes. In recent years, there has been an increase in the use of technology, with health technology tools (ICT) appearing as an intervention to increase physical activity and improve associated health problems.ObjectiveIn this review, we evaluated the effectiveness of health technology to increase physical activity and to improve cardiovascular parameters in older adults.MethodologyStudies with a great variety of health technology tools to increase physical activity levels, and that evaluated the effect of that increase on cardiovascular parameters were included by searching the main databases.ResultsEleven studies reporting the use of a variety of ICT tools were included in this review. Despite these differences, the effectiveness of health technology tool interventions has been demonstrated in increasing physical activity and reducing cardiovascular parameters.DiscussionThe lack of adherence of older adults to health technology would be a disadvantage, but it has been shown that younger older adults are more familiar with health technology tools and the number using them is increasing.ConclusionHealth technology tools show effectiveness in increasing physical activity in older adults and improving cardiovascular parameters. 相似文献
67.
68.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
69.
Neonates with progressive respiratory failure should be referred early for subspecialty evaluation and lung transplantation consideration. ECMO should be considered for patients with severe cardiopulmonary dysfunction and a high likelihood of death while on maximal medical therapy, either in the setting of reversible medical conditions or while awaiting lung transplantation. While ECMO offers hope to neonates that experience clinical deterioration while awaiting transplant, the risks and benefits of this intervention should be considered on an individual basis. Owing to the small number of infant lung transplants performed yearly, large studies examining the outcomes of various bridging techniques in this age group do not exist. Multiple single-centre experiences of transplanted neonates have been described and currently serve as guidance for transplant teams. Future investigation of outcomes specific to neonatal transplant recipients bridged with advanced devices is needed. 相似文献
70.
Association between C1236T Genetic Variant of ABCB1 Gene and Molecular Response to Imatinib in Indonesian Chronic Myeloid Patients 下载免费PDF全文
Ikhwan RinaldiRiki NovaReni WidyastutiRizky PriambodoInstiaty InstiatyMelva Louisa 《Asian Pacific journal of cancer prevention》2019,20(11):3331-3334
Objective: Imatinib is the first-line drug used for the treatment of chronic myeloid leukemia (CML) patients due to high molecular response and overall survival rate. However, some patients develop resistance to imatinib even after attaining a response. Mutation in ABCB1 efflux transporters is one of the known mechanisms of resistance to imatinib in chronic myeloid leukemia patients. This study was aimed to investigate the association of ABCB1 C1236T polymorphism in Indonesian chronic myeloid patients with molecular response to imatinib treatment. Methods: We analyzed 120 samples from chronic myeloid leukemia patients in the chronic phase, who had been on imatinib treatment for at least 12 months. We analyzed the C1236T variant of the ABCB1 gene using PCR, followed by direct sequencing, and associate them with the achievement of major molecular response (MMR). Results: The major molecular response was achieved in 28% of patients. The frequencies of the SNPs were CC (40%), CT (46%), and TT (14%). Our result showed that there was a lack of association between polymorphism of ABCB1 C1236T and imatinib response in Indonesian patients, with OR = 0.646 (95% CI: 0.283, 1.471; p>0.05). Conclusion: There was no association between ABCB1 C1236T variants with the major molecular response in Indonesian chronic myeloid leukemia patients receiving imatinib treatment. 相似文献